Sterling Investment Counsel’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,862
| Closed | -$232K | – | 180 |
|
|
2025
Q1 | $232K | Buy |
+2,862
| New | +$232K | 0.08% | 157 |
|
|
2024
Q4 | – | Sell |
-4,221
| Closed | -$417K | – | 176 |
|
|
2024
Q3 | $417K | Sell |
4,221
-40
| -0.9% | -$3.95K | 0.15% | 99 |
|
|
2024
Q2 | $395K | Buy |
4,261
+273
| +7% | +$25.3K | 0.16% | 89 |
|
|
2024
Q1 | $378K | Buy |
3,988
+740
| +23% | +$70.2K | 0.17% | 94 |
|
|
2023
Q4 | $290K | Sell |
3,248
-54
| -2% | -$4.82K | 0.15% | 114 |
|
|
2023
Q3 | $241K | Hold |
3,302
| – | – | 0.14% | 128 |
|
|
2023
Q2 | $275K | Sell |
3,302
-1
| -0% | -$83 | 0.15% | 116 |
|
|
2023
Q1 | $252K | Buy |
3,303
+54
| +2% | +$4.12K | 0.15% | 130 |
|
|
2022
Q4 | $270K | Buy |
3,249
+644
| +25% | +$53.4K | 0.17% | 127 |
|
|
2022
Q3 | $207K | Sell |
2,605
-300
| -10% | -$23.8K | 0.15% | 131 |
|
|
2022
Q2 | $216K | Hold |
2,905
| – | – | 0.16% | 133 |
|
|
2022
Q1 | $261K | Buy |
+2,905
| New | +$261K | 0.18% | 120 |
|